🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
CCI clears Manipal Group chief Ranjan Pai, 360 One’s investment in PharmEasy
IndianStartupNews
·
1y ago
Medial
Manipal Education and Medical Group (MEMG) and 360 One have been given permission by the Competition Commission of India (CCI) to invest in API Holdings, the parent company of online pharmacy giant PharmEasy. MEMG is expected to invest Rs 1,000 crore for an 18% stake in the company. Ranjan Pai, a previous backer of PharmEasy, will also acquire a significant stake in the company, making him one of the largest investors with over 12% ownership. This investment is part of a larger Rs 3,500-crore rights issue aimed at repaying debt and stabilizing the company's financials.
View Source
Related News
CCI Clears Ranjan Pai, 360 One’s Stake Acquisition In PharmEasy
Inc42
·
1y ago
Medial
Ranjan Pai, Chairman of the Manipal Group, has received approval from the Competition Commission of India (CCI) to invest in online pharmacy company PharmEasy's parent company, API Holdings. This investment will make Pai one of the largest investors in PharmEasy with a stake of over 12% and a seat on the company's board. The CCI has also cleared an additional investment from 360 One in PharmEasy. Pai's investment is part of PharmEasy's INR 3,500 Cr rights issue that concluded in October 2021. PharmEasy has been working towards profitability, reducing losses by 16.23% in FY23.
View Source
CCI clears Ranjan Pai’s investment in PharmEasy
Economic Times
·
1y ago
Medial
The Competition Commission of India (CCI) has approved Ranjan Pai's investment in online pharmacy PharmEasy. Pai's investment is part of a Rs 3,500-crore funding round through a rights issue. Additionally, an investment from 360 One in PharmEasy has also been cleared. This investment positions Pai as one of the largest investors in the Mumbai-based firm. PharmEasy has been addressing debt taken from Goldman Sachs through the rights issue. Pai's strategic direction is expected to guide PharmEasy's growth in the face of competition from rivals like 1mg, Flipkart Health Plus, Apollo, and Netmeds.
View Source
PharmEasy CEO has three-year lock-in, Ranjan Pai to get three board seats
Economic Times
·
1y ago
Medial
PharmEasy CEO has three-year lock-in, Ranjan Pai to get three board seats. The CEO of PharmEasy, Dhaval Shah, will have a three-year lock-in period as part of the company's acquisition deal with API Holdings. Additionally, Ranjan Pai, the chairman of Manipal Education and Medical Group, will receive three board seats in the company. PharmEasy is an online pharmacy and healthcare platform that recently announced a merger with API Holdings, the parent company of diagnostic chain Thyrocare.
View Source
Ranjan Pai’s MEMG and 360 One get CCI nod to invest in API Holdings
Entrackr
·
1y ago
Medial
Competition Commission of India (CCI) has approved a subscription to CCPS B of API holding by Ranjan Pai’s MEMG (Manipal Education and Medical Group) and 360 One. The decision was followed by CCI’s previous approval where multiple combination proposals entailed investments by marquee investors such as Goldman Sachs, Naspers, Temasek, and CDPQ in API Holdings Ltd., the parent company of PharmEasy. While the size of investment from Manipal Education and Medical Group) and 360 One are unknown, MEMG was reportedly looking to invest Rs 1,000 crore for an 18% stake in API Holdings. Pai backed PharmEasy in its early days and eventually exited from the Mumbai-based firm a few years ago. Pai will have three board seats after the investment, filing added. PharmEasy is trying to raise around Rs 3,500 crore for the past three quarters to repay debt which it took from Goldman Sach. The company defaulted on its loan covenant terms with Goldman Sachs and ever since then its valuation slashed nearly around 50% by its investor Janus Henderson. Prior to this, Neuberger Berman reduced PharmEasy’s valuation by 21.4% to $4.4 billion as of February 2023. The company was valued at $5.6 billion at its peak. PharmEasy had reported improved financials in the last fiscal year as its revenue from operations grew 16% to Rs 6,644 crore in FY23. As per the startup data intelligence platform TheKredible, the cost cutting measures helped PharmEasy control its losses by 16% which stood at Rs 2289 crore in the fiscal year ending March 2023.
View Source
Ranjan Pai’s Claypond Capital ropes in former Fireside exec
VCCircle
·
1y ago
Medial
Claypond Capital, the family investment office of Ranjan Pai, Chairman of Manipal Group, has appointed a former Fireside Ventures executive as the firm increases its startup investments. The family office was established after Temasek acquired a $2 billion stake in Manipal Group.
View Source
Ranjan Pai's Manipal Group set to gain majority stake in Blackstone-backed firm
VCCircle
·
3m ago
Medial
Ranjan Pai, chairman of Manipal Education and Medical Group, is set to acquire a controlling stake in a firm backed by private equity giant Blackstone. Currently a minority shareholder in Manipal Hospitals, Pai invests in startups through his family office. This move will expand his influence in the healthcare sector, further complementing his business interests and potentially enhancing Manipal Group's strategic growth and diversification.
View Source
SoftBank sells its stake in IPO-bound FirstCry for ₹435 crore
Livemint
·
1y ago
Medial
Japanese firm SoftBank has reportedly sold a portion of its stake in e-commerce platform FirstCry to three Indian business family groups. This move is in preparation for FirstCry's upcoming public listing, expected next year. SoftBank's stake reduction is about 1.5-2%. FirstCry aims to file its draft papers by the end of 2023 for its IPO. Ranjan Pai of Manipal Group is also considering investments in PharmEasy and Byju's Akash Institute.
View Source
Chaudhry unlikely to return to steer Byju's-owned Aakash Institute: Sources
Economic Times
·
1y ago
Medial
Byju's-owned Aakash Institute has abandoned plans for promoter Aakash Chaudhry to return as the chief executive of the coaching business unit. Manipal group chief Ranjan Pai, who owns a 40% stake in the institute, is now poised to lead the company. Pai has become the largest investor in Aakash, while Chaudhry still holds an 11% stake. A new CEO will be appointed by the board. This development follows unsuccessful negotiations between Byju's and the Aakash promoters, and legal battles faced by Byju's.
View Source
Ranjan Pai’s Claypond Capital ropes in former Wipro-GE Healthcare exec
VCCircle
·
7m ago
Medial
Claypond Capital, led by Manipal Group Chairman Ranjan Pai, has appointed a former Wipro-GE Healthcare managing director as they focus on investing in the medical devices and technology sector.
View Source
After Byju's, Manipal Group's Chairman Ranjan Pai to invest Rs 250Cr in FirstCry
IndianStartupNews
·
1y ago
Medial
Manipal Group Chairman Ranjan Pai is set to invest Rs 250 crore in FirstCry, a leading Indian baby products retailer. The investment will support FirstCry's growth and expansion plans, including its online and offline operations. Pai's investment highlights the ongoing interest and support from established business leaders in the Indian startup ecosystem.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
June 2025
Buddy
Helping your parents when you are miles away
BiteStop
The Pit Stop Your Cravings Deserve
Bloomer
The next generation E-commerce platform
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in